Orally Bioavailable Competitive CCR5 Antagonists-Reference-Cited by-同舟云学术

Orally Bioavailable Competitive CCR5 Antagonists

Published:2004-03-11 Issue:8 Volume:47 Page:1939-1955
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Thoma Gebhard¹,Nuninger François¹,Schaefer Marc¹,Akyel Kayhan G.¹,Albert Rainer¹,Beerli Christian¹,Bruns Christian¹,Francotte Eric¹,Luyten Marcel¹,MacKenzie Duncan¹,Oberer Lukas¹,Streiff Markus B.¹,Wagner Trixie¹,Walter Hansrudolf¹,Weckbecker Gisbert¹,Zerwes Hans-Guenter¹

Affiliation:

1. Novartis Institutes for BioMedical Research, Lichtstrasse 35, WSJ-507.4.12, CH-4056 Basel, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm031046g

Reference48 articles.

1. CCR5 is characteristic of Th1 lymphocytes

2. Expression of the Chemokine Receptors CCR4, CCR5, and CXCR3 by Human Tissue-Infiltrating Lymphocytes

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCR5 antagonist: Promising agents in HIV treatment;Current Trends in Pharmacy and Pharmaceutical Chemistry;2023-11-15

2. Computational Screening of CCR5 Inhibitors as Potential Entry Inhibitor Microbicides Using 3D-QSAR Studies, Docking and Molecular Dynamics Simulation;Current HIV Research;2017-08-25

3. Polysaccharide Derivatives as Unique Chiral Selectors for Enantioselective Chromatography;CHIMIA;2017-08-09

4. CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV;Expert Opinion on Investigational Drugs;2016-11-18

5. Biological and Structural Characterization of Rotamers of C–C Chemokine Receptor Type 5 (CCR5) Inhibitor GSK214096;ACS Medicinal Chemistry Letters;2014-11-12